Dietary fiber, carbohydrate quality and quantity, and mortality risk of individuals with diabetes mellitus. PLoS ONE. 2012;7:e43127. S4.2-20. Micha R, Wallace SK, Mozaffarian D. Red and processed meat con- sumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis. Circulation. 2010;121:2271 83. S4.2-21. Pan A, Sun Q, Bernstein AM, et al. Changes in red meat consump- tion and subsequent risk of type 2 diabetes mellitus: three cohorts of US men and women. JAMA Intern Med. 2013;173:1328 35. S4.2-22. Boul NG, Haddad E, Kenny GP, et al. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA. 2001;286:1218 27. S4.2-23. Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin- dependent diabetes mellitus. N Engl J Med. 1993;329:977 86. S4.2-24. Intensive blood-glucose control with sulphonylureas or insulin com- pared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837 53. S4.2-25. Duckworth W, Abraira C, Moritz T, et al. Glucose control and vas- cular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129 39. S4.2-26. Ray KK, Seshasai SRK, Wijesuriya S, et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet. 2009;373:1765 72. S4.2-27. Zelniker TA, Wiviott SD, Raz I, et al. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of car- diovascular outcome trials. Lancet. 2018. https://doi.org/10.1016/ S0140-6736(18)32590-X. 4.3. High Blood Cholesterol S4.3-1. 